1 1
Out of Stock

Bozpah (Bosentan Monohydrate) 62.5 mg, 10 Ct - Nabiqasim

Bozpah (Bosentan Monohydrate) 62.5 mg, 10 Ct - Nabiqasim

PKR 1,300
PKR 1,300
Out of Stock
Pack Size: 10 Tablets
Bozpah 62.5 mg from Nabiqasim contains Bosentan Monohydrate, a dual endothelin receptor antagonist (ERA). It is a specialized medication used for the treatment of Pulmonary Arterial Hypertension (PAH), a severe...  Read More
Brand: Nabiqasim
SKU: 00665
Country: Pakistan
View full details

Description

Bozpah 62.5 mg from Nabiqasim contains Bosentan Monohydrate, a dual endothelin receptor antagonist (ERA). It is a specialized medication used for the treatment of Pulmonary Arterial Hypertension (PAH), a severe and progressive condition characterized by high blood pressure in the arteries of the lungs. Bozpah works by blocking the effects of endothelin, a potent substance that causes blood vessels to narrow. By blocking endothelin, it helps to relax and widen the pulmonary arteries, reducing the pressure in the lungs and improving exercise capacity.

  • Targeted PAH Treatment: Specifically designed to treat World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension.
  • Improves Exercise Ability: Helps patients with PAH to walk further and perform daily activities with less shortness of breath.
  • Dual Receptor Blockade: Blocks both endothelin-A and endothelin-B receptors for comprehensive vasodilation.
  • Oral Convenience: Provides an effective oral treatment option for a condition that often requires complex therapies.
  • Symptom Management: Aids in reducing symptoms like breathlessness, fatigue, and chest pain.

Composition
Each tablet contains:

  • Bosentan Monohydrate: 62.5 mg

Suggested Usage

  • As directed by the physician

Legal Disclaimer

Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.

Product Overview

Bozpah 62.5 mg from Nabiqasim contains Bosentan Monohydrate, a dual endothelin receptor antagonist (ERA). It is a specialized medication used for the treatment of Pulmonary Arterial Hypertension (PAH), a severe and progressive condition characterized by high blood pressure in the arteries of the lungs. Bozpah works by blocking the effects of endothelin, a potent substance that causes blood vessels to narrow. By blocking endothelin, it helps to relax and widen the pulmonary arteries, reducing the pressure in the lungs and improving exercise capacity.

  • Targeted PAH Treatment: Specifically designed to treat World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension.
  • Improves Exercise Ability: Helps patients with PAH to walk further and perform daily activities with less shortness of breath.
  • Dual Receptor Blockade: Blocks both endothelin-A and endothelin-B receptors for comprehensive vasodilation.
  • Oral Convenience: Provides an effective oral treatment option for a condition that often requires complex therapies.
  • Symptom Management: Aids in reducing symptoms like breathlessness, fatigue, and chest pain.

Composition
Each tablet contains:

  • Bosentan Monohydrate: 62.5 mg

Suggested Usage

  • As directed by the physician

Legal Disclaimer

Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.

Product Overview

Bozpah 62.5 mg from Nabiqasim contains Bosentan Monohydrate, a dual endothelin receptor antagonist (ERA). It is a specialized medication used for the treatment of Pulmonary Arterial Hypertension (PAH), a severe and progressive condition characterized by high blood pressure in the arteries of the lungs. Bozpah works by blocking the effects of endothelin, a potent substance that causes blood vessels to narrow. By blocking endothelin, it helps to relax and widen the pulmonary arteries, reducing the pressure in the lungs and improving exercise capacity.

  • Targeted PAH Treatment: Specifically designed to treat World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension.
  • Improves Exercise Ability: Helps patients with PAH to walk further and perform daily activities with less shortness of breath.
  • Dual Receptor Blockade: Blocks both endothelin-A and endothelin-B receptors for comprehensive vasodilation.
  • Oral Convenience: Provides an effective oral treatment option for a condition that often requires complex therapies.
  • Symptom Management: Aids in reducing symptoms like breathlessness, fatigue, and chest pain.

Composition
Each tablet contains:

  • Bosentan Monohydrate: 62.5 mg

Suggested Usage

  • As directed by the physician

Legal Disclaimer

Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.